ATC code L: Antineoplastic and immunomodulating agents |
---|
Other ATC codes |
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] [3] [4]
Codes for
veterinary use (
ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.
[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Major chemical drug groups – based upon the
Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism ( A) | |
blood and blood forming organs ( B) | |
cardiovascular system ( C) | |
skin ( D) | |
genitourinary system ( G) | |
endocrine system ( H) | |
infections and infestations ( J, P, QI) | |
malignant disease ( L01–L02) | |
immune disease ( L03–L04) | |
muscles,
bones, and joints ( M) | |
brain and nervous system ( N) |
|
respiratory system ( R) | |
sensory organs ( S) | |
other ATC ( V) | |
CI monoclonal antibodies ("-mab") |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Tyrosine kinase inhibitors ("-nib") |
| ||||||||
Other |
|
Endogenous |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exogenous |
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
| ||||||||||||||
Unsorted |
|